How Human Challenge Trials Can Accelerate Vaccine Development

Other recent posts

Article

Pharma Focus Asia, Issue 52, 2023 – Human Challenge Trials: Establishing early risk-benefit in development of vaccines and therapies for infectious diseases

Featured on pages 54-56

View Link

Scientific Paper

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study

Effectively implementing strategies to curb SARS-CoV-2 transmission requires understanding who is contagious and when. Although viral load on upper respiratory swabs has commonly been used to infer contagiousness, measuring viral...

View Link

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.